Techlab Inc
Business Identifier: rapid non-invasive intestinal diagnostics in the areas of intestinal inflammation, antibiotic associated diarrhea and parasitology
Public Profile:
TECHLAB, Inc. develops, manufactures, and distributes non-invasive intestinal diagnostics in the areas of intestinal inflammation, antibiotic associated diarrhea and colitis, and parasitology. Its products include an ELISA for the qualitative detection of human anti-S. cerevisiae antibodies in feces; an enzyme immunoassay to detect glutamate dehydrogenase; a membrane enzyme immunoassay to detect Clostridium difficile antigen, glutamate dehydrogenase, in fecal specimens; a membrane enzyme immunoassay to detect clostridium difficile glutamate dehydrogenase antigen, and toxins A and B; and a tissue culture assay to detect clostridium difficile toxin B in fecal specimens. The company also provides an ELISA to detect clostridium difficile toxins A and B in fecal specimens; a toxin/antitoxin kit to detect of clostridium difficile toxin; an ELISA to detect clostridium perfringens enterotoxin; and monoclonal antibody-based ELISA products to detect cryptosporidium oocyst antigen, entamoeba histolytica adhesion, and giardia lamblia in fecal specimens. In addition, it offers tests for the simultaneous detection and differentiation of giardia cyst antigen and cryptosporidium oocyst antigen; ELISA products to detect elevated levels of lactoferrin and fecal lactoferrin; immunochromatographic tests to detect fecal lactoferrin; and a test for the detection and differentiation of shiga toxin 1 and shiga toxin 2 in a test device. Further, the company provides a format that uses antibodies specific for toxins A and B of C. difficile; and various accessories. It offers its products through distributors to customers worldwide. The company was founded in 1989 and is based in Blacksburg, Virginia.

 Synopsis: Awardee Business Condition
Year Founded IP Holdings
Employee Range VC funded?
Revenue Range Private/Public
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Alum-Absorbed Subunit Vaccine To Prevent Intestinal Amebiasis
Point-Of-Care Diagnostic Test For Entamoeba Histolytica Cysts
Multiplex Diagnostic For Enteric Category B Pathogens And Intestinal Biomarkers
Multiplex Screening Elisa For Giardia, Cryptosporidium And E. Histolytica
Mucin-degrading microflora for prophylactic antibiotics